RESPIRATORY PANEL WITH SARS-COV-2 **INHOUSE MOLECULAR TEST**

Test Code
SARSRPANEL


Alias/See Also
RESPIRATORY PANEL WITH COVID-19
**INHOUSE MOLECULAR TEST**
 


Includes
SARS-CoV2, ADENOVIRUS, CORONAVIRUS 229, CORONAVIRUS HKU, CORONAVIRUS NL,
CORONAVIRUS OC, METAPNEUMOVIRUS, RHINO/ENTEROV, INFLUENZA A H1, 
FLU A H1-2009, INFLUENZA A H3, INFLUENZA B, PARAINFLUENZA 1,  PARAINFLUENZA 2,
PARAINFLUENZA 3, PARAINFLUENZA 4, RSV, B PARAPERTUSSIS, B PERTUSSIS,
C. PNEUMONIAE, MYCO PNEUMO


Preferred Specimen
Nasopharyngeal swab collected in M4 (Viral) Media


Instructions
NASOPHARYNGEAL COLLECTED BY RN OR LABORATORY MLS/MLT


Transport Container
M4 VIRAL TRANSPORT MEDIA


Specimen Stability
Frozen: 1 year
Refrigerated: 72 hours
Room Temp: 24 hours


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Nasal Saline Specimens


Methodology
Polymerase chain reaction (PCR) - BioFire FilmArray

FDA Status
Emergency Use Authorization

Limitations
This test is performed using rt-PCR for the detection of
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
on the BioFire Respiratory Panel 2.1 assay, BioFire
Diagnostics.
This test has been authorized by the FDA under Emergency Use
Authorization (EUA). Authorization for use is approved until
the public health emergency is terminated or the EUA is
revoked by the FDA.


Reference Range
Negative


Clinical Significance
The BioFire SARS Respiratory panel is a real-time, nested multiplexed polymerase chain reaction test designed to simultaneously identify nucleic acids from 21 different viruses and bacteria associated with respiratory tract infections, including SARS-CoV-2, from a single nasopharyngeal swab specimen.


Performing Laboratory
LMH-Microbiology



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.